Duchenne/Becker Muscular Dystrophy Registry for patients and carriers
Official title: Development and Implementation of a Transparent Registry Based on FAIR Principles for Duchenne and Becker Muscular Dystrophy (DBMD) Under the Auspices of the Society for Neuropediatrics (GNP) - FAIR-DMD
Run by University Hospital Heidelberg · NCT07402122 · Data updated 2026-11-12
This registry tests whether patients with Duchenne or Becker muscular dystrophy, or symptomatic female carriers, can be enrolled and followed across specialist centers to improve data sharing and care.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | University Hospital Heidelberg Academic / other |
| Locations | 30 sites (Graz and 29 other locations) |
| Status | Recruiting |
| Started | July 13, 2026 |
| Main results expected | December 2040 |
| Study ends | June 2041 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07402122 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are genetically confirmed males with Duchenne/Becker muscular dystrophy or symptomatic female carriers treated at participating centers who can use a tablet or smartphone and consent to data sharing.
✕Probably not a fit
Patients not using a tablet/smartphone or not receiving care at a participating center may not directly benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The FAIR-DMD registry is an observational, disease-specific registry coordinated by academic centers to collect and share data about individuals with Duchenne and Becker muscular dystrophy. It emphasizes Findable, Accessible, Interoperable, and Reusable data to support collaboration across European centers. Participation requires genetic confirmation of dystrophinopathy, treatment at a participating center, informed consent, and access to a smartphone or tablet for data exchange. Data collection includes clinical characteristics, treatments, and outcomes to inform future research and care strategies. The registry aims to interoperate with existing registries such as the Swiss-Reg-NMD and to enable broader data exchange among European Duchenne registries.
Why it matters
Potential benefit: If successful, the registry could improve data sharing among centers, enhance patient care planning, and accelerate research collaborations for Duchenne and Becker muscular dystrophy.
How similar studies have gone: Registries for Duchenne and related dystrophinopathies have facilitated data sharing and collaboration, though this specific interoperable European registry approach is evolving.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Genetically confirmed diagnosis of dystrophinopathy * Female carriers only if they show clinical symptoms of a dystrophinopathy * Treatment in one of the participating centers * No age restrictions * Ability to understand the patient information and sign the informed consent * Consent capability by the patient themselves and/or by the parents * Agreement to data exchange between the treating physicians, the telemedicine platform, and the registry * Possession of a tablet or a smartphone Exclusion Criteria: * Missing legally valid consent form from the patient and/or legal guardians * Project content is not understandable to the participant and/or legal guardians * Not in possession of a tablet or smartphone
Where it's running
-
Tirol Kliniken, Landeskrankenhaus Innsbruck
Innsbruck, Austria Recruiting -
Charité - Universitätsmedizin Berlin
Berlin, Germany Recruiting -
DRK Kliniken Berlin Westend
Berlin, Germany Recruiting -
Universitätsklinikum Bonn, Zentrum für Kinderheilkunde
Bonn, Germany Recruiting -
Universitätsklinikum Carl Gustav Carus TU Dresden
Dresden, Germany Recruiting -
Universitätsklinikum Erlangen
Erlangen, Germany Recruiting
Show 24 more locations
-
Universitätsklinikum Essen Klinik für Kinderheilkunde I
Essen, Germany Recruiting -
Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany Recruiting -
Universitätsklinikum Gießen und Marburg, Standort Gießen
Giessen, Germany Recruiting -
Universitätsmedizin Greifswald
Greifswald, Germany Recruiting -
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany Recruiting -
Medizinische Hochschule Hannover
Hanover, Germany Recruiting -
Universitätsklinik Heidelberg, Zentrum für Kinder- und Jugendmedizin
Heidelberg, Germany Recruiting -
Universitätsklinikum des Saarlandes
Homburg, Germany Recruiting -
Gesundheit Nordhessen Klinikum Kassel
Kassel, Germany Recruiting -
Universitätsklinikum Leipzig, Klinik und Poliklinik für Kinder- und Jugendmedizin
Leipzig, Germany Recruiting -
LMU Klinikum München; Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
München, Germany Recruiting -
Universitätsklinikum Münster
Münster, Germany Recruiting -
Universitätsklinikum Tübingen, Universitätsklinik für Kinder- und Jugendmedizin
Tübingen, Germany Recruiting -
LKH Universitätsklinikum Graz
Graz, Austria Not yet recruiting -
Kepler Universitätsklinkum Linz
Linz, Austria Not yet recruiting -
Landeskrankenhaus Salzburg
Salzburg, Austria Not yet recruiting -
Wiener Gesundheitsverbund, Klinik Favoriten
Vienna, Austria Not yet recruiting -
Katholisches Klinikum -Universitätsklinikum der Ruhr-Universität Bochum
Bochum, Germany Not yet recruiting -
Gesundheit Nord gGmbH Klinikverbund Bremen
Bremen, Germany Not yet recruiting -
Universitätsmedizin Göttingen
Göttingen, Germany Not yet recruiting -
Asklepios Klinik Nord-Heidberg
Hamburg, Germany Not yet recruiting -
Universitätsklinikum Jena
Jena, Germany Not yet recruiting -
Klinikum Stuttgart, Olgahospital
Stuttgart, Germany Not yet recruiting -
Universitätsklinikum Ulm
Ulm, Germany Not yet recruiting
Study contacts
- Principal investigator: Ulrike Schara-Schmidt, Prof. Dr. — Universitätsklinikum Essen, Klinik für Kinderheilkunde
- Study coordinator: Andreas Ziegler, Dr.
- Email: FAIR-DMD@med.uni-heidelberg.de
- Phone: 004962215632207
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Duchenne/Becker Muscular Dystrophy EHR Data Linkage
This study tests whether consented patients’ electronic health records can be linked with the Duchenne Registry data to create a richer view of Duchenne and Becker muscular dystrophy care.
-
Modeling heart failure in Duchenne and Becker muscular dystrophy to find surrogate heart measures
This study will look at heart disease in people with Duchenne/Becker muscular dystrophy and carriers to see if MRI-based heart measures can predict death or major heart problems.
-
DMD gene changes and heart function in boys and young men with dystrophinopathies
This study will test whether specific DMD gene changes and routine heart tests (blood biomarkers, ECG, and echocardiography) can help identify early heart problems in boys and young men aged 2–24 with genetically confirmed dystrophinopathies.
-
An online registry for Duchenne and Becker muscular dystrophy patients
This study is creating an online registry to help people with Duchenne and Becker muscular dystrophy connect with clinical trials and find helpful information about their condition.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
Bone health in adults with Duchenne muscular dystrophy: osteoporosis, fractures, and treatment
This study looks at how common bone problems and fractures are in adults with Duchenne muscular dystrophy and what factors from childhood might affect bone health later on.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.